Biotech Hiring Dependent on Location
05/04/2010
According to an article at the Boston Business Journal, many big biotech companies in the Massachusetts area are hiring hundreds of workers to propel new products and operate new facilities in an effort to regain ground lost in the past two years. Many are also looking to rely more on outsourced services providers, which in turn, are also looking to bring on more staff.
For example two Massachusetts-based life sciences groups have busy HR departments these days. Shire has already hired 180 workers this year to support a new plant and product manufacturing and aims to hire on another 180 by year's end. Genzyme Corp. has over 680 jobs open at present, all tied to supporting a new $300 million plant.
The hiring will continue in the future as a new plant is also coming on line at year's end and a new drug is nearing regulatory approval.
But the biotech job front is a bit different on the other side of the country, according to California news reports. Hiring, for example, is slowing down at places located in the Bay Area. A recent job fair at a university campus only pulled in about half the bio tech companies it did last year.
The Bay Area biotech trade organization, BayBio, attributes the hiring slowdown to the recession and a series of mergers, sell-offs, and drug failures are to blame.
About 130,000 professionals work in biotech in Northern California and while employment has been growing at a rate of 2,000 each year, it's far from the pace of 6,000 new hires annually, according to BayBio.
Most Read
-
-
2020 Top States for Doing Business Showcase Their Pro-Business Environments
Q3 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020
-
“Made in America” Executive Order to Affect International Companies and FDI
Q1 2021
-
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2020
-
Pandemic Fuels Data Center Growth
Q1 2021
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019